September 4, 2024
“…COMPASS Pathways (CMPS)… Morgan Stanley analyst Vikram Purohit, who covers the stock, sees CMPS as presenting a compelling risk-reward opportunity. He highlights the company’s leading clinical program… To this end, Purohit rates CMPS shares an Overweight (i.e. Buy), and his $23 price… Continue Reading…
August 12, 2024
“CervoMed (CRVO) The first Morgan Stanley pick we’ll look at is CervoMed, a clinical-stage medical research firm specializing in neurodegenerative diseases and conditions… Overall, the analyst expects positive clinical results and rates CRVO an Overweight (i.e., Buy). His $35 price… Continue Reading…
July 31, 2024
“…RegenXBio (RGNX) The first Goldman pick we’ll look at is RegenXBio, a gene therapy company specializing in single-dose treatments for severe diseases with few or no existing therapies…. Choi rates RGNX a Buy along with a $38 price target. This… Continue Reading…
July 2, 2024
“Veteran strategist Chris Vermeulen, of The Technical Traders, believes he is witnessing troubling signals in the market, noting how borrowing costs are expected to remain high for an extended period. Vermeulen notes how building numbers for single- and multi-family homes have… Continue Reading…
May 13, 2024
“Auna S.A. (AUNA)… Cepeda’s views back up his Overweight (Buy) rating on the stock, and his $14 price-target points toward a robust 110% upside potential for the next 12 months. (To watch Cepeda’s track record, click here)… Contineum Therapeutics (CTNM)… Hung goes… Continue Reading…
December 29, 2023
“…Dubravko Lakos-Bujas, the chief global equity strategist at JPMorgan, said in a recent analyst note that slowing economic growth, the rapid depletion of household savings and ongoing geopolitical turmoil could trigger a steep decline in the S&P 500 over the course of… Continue Reading…
January 3, 2022
“…Semiconductor sales are expected to grow by another 9% and cross $600 billion for the first time in 2022, the analysts predicted. That’s on top of the 26% growth to $553 billion in 2021, they added. A months-long semiconductor shortage… Continue Reading…
May 6, 2021
““Bitcoin is going to $1 million a coin,” CoinDesk Learn Editor Ollie Leech said. “I actually believe that it will, at some stage, with just the scarcity aspect alone, it makes it an incredibly exciting asset to hold… Bitcoin is… Continue Reading…
March 15, 2021
“Economists at Goldman Sachs raised their GDP growth expectations for the U.S. economy to 8% for 2021 in a note to clients on Sunday night… What they’re saying: “We have raised our GDP forecast to reflect the latest fiscal policy news… Continue Reading…
Recent Comments